Agenus | AGEN - Ingresos Por Ventas





Ventas Cambio Fecha
AbbVie USD 16.99B 1.99B 2026-06
Agenus USD 33.7M 500K 2026-03
Amgen USD 10.1B 1.48B 2026-06
AstraZeneca USD 15.38B 90M 2026-06
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Celldex Therapeutics USD 22K 7K 2026-06
CSL USD 8.33B 4.79B 2025-12
Eli Lilly USD 22.97B 3.17B 2026-06
Gilead Sciences USD 7.8B 800M 2026-06
GlaxoSmithKline GBP 8.41B 781M 2026-06
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Incyte USD 1.67B 400M 2026-06
Intrexon USD 717K 511K 2024-06
J&J USD 25.31B 1.21B 2026-06
Jiangsu Hengrui CNY 8.63B 490M 2026-06
Karyopharm Therapeutics USD 35.07M 987K 2026-03
MacroGenics USD 20.8M 20.43M 2026-03
Merck EUR 5.43B 300M 2026-06
Merck USD 16.6B 310M 2026-06
Northwest Biotherapeutics USD 494K 294K 2026-03
Novartis USD 14.41B 1.3B 2026-06
Novavax USD 147.14M 76.69M 2025-12
Pfizer USD 15.03B 530M 2026-06
Regeneron Pharmaceuticals USD 4.29B 690M 2026-06
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Sangamo BioSciences USD 356K 125K 2024-06
Veracyte USD 150.32M 11.25M 2026-06